The Unique U.S.-Russian Relationship in Biological Science and Biotechnology: Recent Experience and Future Directions (2013)
Chapter: Appendix F.5: Scientific Forum for Biomedical and Behavioral Research
Scientific Forum for Biomedical and Behavioral Research
Results are presented below of a November 2011 meeting in Moscow, organized under the auspices of the Foundation for the National Institutes of Health, to foster U.S.-Russia scientist-to-scientist collaboration and to organize training courses for Russian scientists.
A: THEMATIC AREAS OF INTEREST
Active and healthy lifestyles
Brain sciences
Cancer
Human development
Cardiovascular disease
Infectious and rare disease
Clinical and translational research training
B: PARTICIPATING COMPANIES
Eli Lilly, Amway, Amgen, Abbott, Coca Cola, Johnson and Johnson, Genzyme, Pfizer, Pepsi Cola, Bristol Myers Squibb, Bach Pharma, Celgene, Merck, Genetic Alliance, Novartis, ChemDiv, and ChemRar.
C: ONGOING AND PROPOSED PROJECTS
1: Conjugated Vaccine againstPseudomonas aeruginosa
• Interested Russian organizations: Zelinsky Institute of Organic Chemistry, High Chemical College, Mechnikov Institute of Vaccines and Sera, Federal State Unitary Company Microgen Scientific Industrial Company for Immunobiological Medicines
• Interested U.S. organization: Harvard Medical School
2: Simultaneous Multitarget Therapy of Tumors
• Interested Russian organizations: Institute of Chemical Biology and Fundamental Medicine, Vavilov Institute of General Genetics, Institute of Gene Biology, Institute of Molecular Genetics, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Blokhin Cancer Center
3: Modular Nanotransporters and Chemically Synthesized Modules
• Interested Russian organization: Institute of Gene Biology
• Interested U.S. organization: Duke University
4: HIV-Tuberculosis Diagnosis and Drug Discovery
• Interested Russian organizations: Ivanovsky Institute of Virology, Central Research Institute of Tuberculosis, Central Research Institute of Epidemiology, Vavilov Institute of General Genetics; Institute of Organic Synthesis; Institute of Organic Chemistry
• Interested U.S. partners: Ely Lilly, Infectious Disease Research Institute of Seattle
5: Medical Proteomics in the Context of Bioinformatics Strategy DELSA (Data-Enabled Life Sciences)
• Interested Russian organization: Institute of Biomedical Chemistry
• Interested U.S. organizations: Houston Children’s Hospital, Fred Hutchinson Cancer Research Center, Center for Computational Medicine and Biology at the University of Michigan, Department of Chemistry and Chemical Biology at Northeastern University
6: Human Microbiome: Metagenomics, New Biomarkers of Disease, Translational Research in Personalized Medicine
• Interested Russian organizations: Vavilov Institute of General Genetics, Institute of Chemical Biology and Fundamental Medicine (Novosibirsk), Institute of Biomedical Problems, Moscow State University, Research Institute of Physical-Chemical Medicine
• Interested U.S. organizations: Institute for Genome Sciences, University of Maryland School of Medicine, George Mason University
7: Preclinical Development and Preventive Treatment of Neurodegenerative Disease
• Interested Russian organizations: Institute of Developmental Biology, Institute of Molecular Genetics, Institute of Bioorganic Chemistry, Institute of Physiologically Active Substances, Institute of Evolutionary Physiology and Biochemistry (St. Petersburg), Institute of Normal Physiology, Zakusov Institute of Pharmacology, Moscow State Medical University
• Interested U.S. organizations: National Institute of Neurological Disorders and Stroke, Washington University, Institute for Degenerative Disorders
D: PROPOSED FORUM MEETINGS
2012: Rare Diseases and Drug Development
2013: Brain Sciences
2014: Infectious Diseases and Cancer
2015: Healthy Lifestyles and Cardiovascular Diseases
E. POTENTIAL FUNDING ORGANIZATIONS IN RUSSIA
Ministry of Education and Science, Ministry of Industry and Trade, Skolkovo Foundation
SOURCE: Ann Ashby, NIH Foundation (Ann.Ashby@NIH.gov).
This page intentionally left blank.
